Last updated: June 5, 2023
Sponsor: NIH Natl Institute on Aging
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mild Cognitive Impairment
Alzheimer's Disease
Treatment
N/AClinical Study ID
TX312803
22-37848
Ages 50-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 50-year-old and above
- Self-identified as Chinese American
- Cognitively healthy individuals OR clinically diagnosed with mild cognitive impairment OR clinically diagnosed with Alzheimer's disease.
- Speaks either Mandarin, Cantonese, English
Exclusion
Exclusion Criteria:
- Individuals with history of brain surgery, major brain trauma (ICU hospitalized), symptomatic stroke, brain tumor, and other neurological diseases that impacts cognitive functions
- Individuals with visual impairment that affect participant’s ability to visualize study materials
- Severe hearing impairment (>70db)
- Contraindicated for Magnetic Resonance Imaging (MRI) including pregnancy, intraocular or intracranial metal implants, cardiac pacemaker or claustrophobia
Study Design
Total Participants: 600
Study Start date:
May 01, 2023
Estimated Completion Date:
March 31, 2028
Study Description
Connect with a study center
University of California, San Francisco
San Francisco, California 94158
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.